Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,731,500
-
Total 13F shares
-
41,360,707
-
Share change
-
-1,889,525
-
Total reported value
-
$72,857,551
-
Put/Call ratio
-
44%
-
Price per share
-
$1.76
-
Number of holders
-
73
-
Value change
-
-$1,829,065
-
Number of buys
-
30
-
Number of sells
-
50
Institutional Holders of Marinus Pharmaceuticals, Inc. - Common Stock (MRNS) as of Q3 2024
As of 30 Sep 2024,
Marinus Pharmaceuticals, Inc. - Common Stock (MRNS) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,360,707 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, abrdn plc, Bleichroeder LP, BlackRock, Inc., and Woodline Partners LP.
This page lists
72
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.